Login / Signup
Editorial: glecaprevir/pibrentasvir for the treatment of hepatitis C virus-do baseline resistance-associated substitutions matter?
Allison J Kwong
Paul Yien Kwo
Published in:
Alimentary pharmacology & therapeutics (2020)
Keyphrases
</>
hepatitis c virus
human immunodeficiency virus
replacement therapy